India’s Covaxin effectively neutralises both Alpha and Delta variants of coronavirus, said the US’ National Institute of Health (NIH). The NIH said that the results of two studies of blood serum that was taken from people who had received Covaxin suggest that the vaccine generates antibodies that effectively neutralise the B.1.1.7 (Alpha) and B.1.617 (Delta) variants of SARS-CoV-2.
Discuss about the question